CIK 0001372514
- Non-accelerated filer
- Smaller reporting company
KIORA PHARMACEUTICALS INC
Sign in to watch- Tickers
- KPRX KPHMW
- Exchange
- Nasdaq, OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 980443284
- Phone
- +1 858-224-9600
- Business address
- 169 SAXONY RD., SUITE 212, ENCINITAS, CA, 92024
- Former names
- EYEGATE PHARMACEUTICALS INC
Securities
- KPRX Common Stock Nasdaq
- KPHMW Common stock OTC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 73 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-02-01 | GOLDBERG MORTON Director | Grant or award · Stock Option (right to buy) | +3,333 | 3,333 | ||
| 2020-02-14 | GOLDBERG MORTON Director | Grant or award · Stock Option (right to buy) | +3,333 | 3,333 | ||
| 2019-12-06 | GOLDBERG MORTON Director | Sale | −1,961 | $6.93 | $14K | 0 |
| 2019-11-12 | GOLDBERG MORTON Director | Sale | −2,001 | $4.29 | $9K | 1,961 |
| 2019-02-01 | GOLDBERG MORTON Director | Grant or award · Stock Option (right to buy) | +50,000 | 50,000 | ||
| 2018-07-10 | GOLDBERG MORTON Director | Grant or award | +50,000 | 59,441 | ||
| 2017-06-21 | GOLDBERG MORTON Director | Grant or award · Stock Option (right to buy) | +15,000 | 15,000 | ||
| 2017-03-06 | GOLDBERG MORTON Director | Sale | −8,919 | $3.00 | $27K | 9,441 |
| 2017-02-27 | GOLDBERG MORTON Director | Exercise or conversion | +1,083 | $1.70 | $2K | 18,360 |
| 2017-02-27 | GOLDBERG MORTON Director | Exercise or conversion · Stock Option (right to buy) | −1,083 | 1,917 |
Page 1 of 1 · 10 trades